University Health Network
🇨🇦Canada
Dexamethasone in Total Knee and Total Hip Arthroplasty
Phase 2
- Conditions
- Total Knee ArthroplastyTotal Hip ArthroplastyOsteoarthritis
- Interventions
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 314
- Registration Number
- NCT02760043
- Locations
- 🇨🇦
Toronto Western Hopspital, Toronto, Ontario, Canada
Tri-modal Imaging Instrument for Thyroid Cancer
Not Applicable
Completed
- Conditions
- Thyroid NeoplasmsThyroid CancerThyroid Nodule
- Interventions
- Device: Tri-modal imaging
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 9
- Registration Number
- NCT02758158
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Perfusion CT Imaging in Lung Cancer With SBRT
Not Applicable
Completed
- Conditions
- Lung Cancer
- Interventions
- Device: Perfusion CT Imaging
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 9
- Registration Number
- NCT02755454
- Locations
- 🇨🇦
Patrik Rogalla, Toronto, Ontario, Canada
Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients
Not Applicable
Terminated
- Conditions
- Leukemia
- Interventions
- Device: Ultralow Dose Thoracic Computed Tomography
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2018-10-30
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 119
- Registration Number
- NCT02755480
- Locations
- 🇨🇦
Toronto General Hospital, Department of Medical Imaging, Toronto, Ontario, Canada
Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
Active, not recruiting
- Conditions
- Carcinoma, Pancreatic Ductal
- Interventions
- Genetic: Molecular Profiling
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 332
- Registration Number
- NCT02750657
- Locations
- 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦McGill University Health Centre, Montréal, Quebec, Canada
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma, Non-Hodgkin's
- Interventions
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT02750670
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)
Phase 4
Completed
- Conditions
- Oxygenation During One Lung Ventilation
- Interventions
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2019-05-17
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 8
- Registration Number
- NCT02748265
- Locations
- 🇨🇦
Toronto General Hospital, 200 Elizabeth St., Toronto, Ontario, Canada
Hyperbaric Oxygen Therapy and Acute Kidney Injury
Not Applicable
Terminated
- Conditions
- Acute Kidney Injury
- Interventions
- Other: Standard therapyOther: Hyperbaric Oxygen
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2019-05-17
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 7
- Registration Number
- NCT02743754
- Locations
- 🇨🇦
Toronto General Hopsital University Health Network, Toronto, Ontario, Canada
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Not Applicable
Active, not recruiting
- Conditions
- Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 195
- Registration Number
- NCT02743741
- Locations
- 🇨🇦
Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦Juravinski Cancer Centre, Hamilton, Ontario, Canada
Assessment of Intranasal Glucagon on Endogenous Glucose Production
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 10
- Registration Number
- NCT02740829
© Copyright 2025. All Rights Reserved by MedPath